Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006033
Status:
COMPLETED
Last Update Posted:
2013-05-30
First Post:
2000-07-05
Brief Title:
Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer
Sponsor:
Organization:
National Cancer Institute NCI